Kelyniam Global, Inc., (KLYG), a maker of patient specific craniofacial and skull implants, announced the submission of its third 510(k) application to the FDA to expand their line of custom implants. “The 510(k) submission is the result of our significant investments in research and development and in the quality infrastructure to successfully pursue regulatory applications,”...Read More
Kelyniam Global (KLYG), a maker of custom cranial implants, announced the acquisition of new additive manufacturing technology to increase current medical modeling capabilities. “This state-of-the-art equipment will enable Kelyniam to produce certain medical models on the same 24-hour turnaround schedule we offer for cranial implants,” said Chris Breault, Kelyniam’s Chief Operating Officer. “The ability to rapidly...Read More
Dear Shareholder, 2017 marks the first year since 2014 that the company has published financial information. You can now find financial information for 2015 and 2016 on our website, Kelyniam.com. Reporting financial information is just one example of the many positive changes happening at Kelyniam. I am pleased to report that year over year revenues...Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has signed a multi-year distribution agreement with a leading medical device distributor in the neuroscience market. Dr. Mark Smith, Kelyniam’s Vice President of Sales said, “This agreement is in alignment with our sales strategy of building long-term relationships with...Read More
CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, announced today that it has hired Ross Bjella as Chairman and Chief Executive Officer. The company had recently appointed Chris Breault as Chief Operating Officer after the former President, Tennyson Anthony, left the company in April of this year. The company has also...Read More
Canton, CT, June 3, 2014 (GLOBE NEWSWIRE) — Kelyniam Global Inc, (OTC: KLYG), a prominent manufacturer of custom cranial implants, today reported that the company generated net income of $71,205 in the first quarter of 2014. Compared with first quarter 2013, net sales increased 23% from $437,415 to $540,286, as a result of increased market...Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments